Clinical Trial Update: Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women [NA]

View source ↗

Summary

An ongoing clinical trial update assessing potential drug–drug interactions between feminizing hormone therapy and emtricitabine/tenofovir alafenamide for HIV p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide) (emtricitabine/tenofovir alafenamide)
• Feminizing hormone therapy

Snippet

Sponsor: Thai Red Cross AIDS Research Centre | Conditions: Drug Interaction | NA | Status: ACTIVE_NOT_RECRUITING